Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05544162 · ClinicalTrials.gov registry record · NA

Personalized Nutrition Delivery to Improve Resilience in Older Adult Trauma Patients

A NA study of Critical Illness and Trauma, sponsored by Duke University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05544162: Completed NA study of Critical Illness and Trauma, sponsored by Duke University.

NCT05544162 is a NA study of Critical Illness and Trauma that has completed, run by Duke University. The registered enrollment target is 40 participants, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05544162, a NA study of Critical Illness and Trauma, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a Pilot study designed to set up for an randomized clinical trial (RCT) comparing the SeND Home pathway to a standard of care nutrition delivery in critically ill older adult trauma patients. Subjects will be randomized 3:1 to either SeND Home precision nutrition pathway or control arm. Subjects randomized to the SeND Home arm will receive oral nutrition supplements (ONS) up to 3 times per day while in the hospital and for 4 weeks after discharge. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers. Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass.

Primary Outcome

This outcome is a measure of feasibility of the SeND Home pathway

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Nutrition supplement - Ensure shakes

Study Locations (1)

North Carolina

  • Duke University Hospital - Durham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-01-05
Est. Completion 2024-07-26
Phase NA
Duke University

1,725 total trials

What the finished NCT05544162 record still lists

NCT05544162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Nutrition supplement - Ensure shakes is the first listed.

NCT05544162 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05544162 about?

NCT05544162 is a clinical study titled "Personalized Nutrition Delivery to Improve Resilience in Older Adult Trauma Patients". This is a Pilot study designed to set up for an randomized clinical trial (RCT) comparing the SeND Home pathway to a standard of care nutrition delivery in critically ill older adult trauma patients. Subjects will be randomized 3:1 to either SeND Home precision nutrition pathway or control arm. Subj...

What is the current status of trial NCT05544162?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-01-05. Estimated completion is 2024-07-26.

What conditions does trial NCT05544162 study?

This clinical trial studies the following conditions: Critical Illness, Trauma.

What interventions are being tested in trial NCT05544162?

The interventions under investigation include: Nutrition supplement - Ensure shakes (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05544162?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05544162 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05544162's enrollment target sits among peer trials

40 80th of 91 higher than 10 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05544162, the US trial registry maintained by the National Library of Medicine. NCT05544162 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.